Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation
Journal of the American Heart Association · 07.10.2025 · 14 (19)
DOI: 10.1161/jaha.124.039977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.10.2025. Verfasst von Cooper Quartermaine und 23 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Oncology Program, Division of Cardiology The Ohio State University Medical Center Columbus OH USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Hematopoietic Stem Cell Transplantation, Atrial Fibrillation, Heart Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Allogeneic hematopoietic stem cell transplantation (alloHSCT) has been associated with serious cardiotoxicity, including atrial fibrillation (AF) and other cardiac events. In preclinical models, posttransplant clonal hematopoiesis (CH) frequently parallels or precedes clinical AF, yet whether this is seen in patients or has implications for cardiotoxic risk in long‐term follow‐up is unknown.
Methods
Leveraging consecutive patients treated with alloHSCT, genotyped using deep‐amplicon sequencing to detect the presence of CH, we assessed the development of new (incident) AF, by CH status. Secondary outcomes were the occurrence of major adverse cardiac events, defined as heart failure, myocardial infarction, AF, symptomatic ventricular arrhythmias, and cardiovascular death after alloHSCT. We also assessed the relation between CH and post‐alloHSCT cancer survival outcomes. Observed incident AF rates were compared with Framingham heart predicted rates. Multivariable regression and survival analyses were used to define the relation between CH and incident AF, major adverse cardiac events, progression‐free survival, and overall survival. We also explored these relationship by specific mutation and by varying variant allele frequency.
Results
Overall, 201 patients with deep sequencing after alloHSCT were identified (median age, 59 years; 46.3% with hypertension; and 42.3% with CH, including 29.5% with ≥2 mutations). Over a median follow‐up of 35 months, 11.5% of patients developed incident AF, and 29.9% experienced major adverse cardiac events. In those without prior AF, the weighted‐average incidence was 407 per 10 000 person‐years compared with the Framingham‐predicted 63 per 10 000 person‐years (risk ratio, 6.4; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardio-Oncology Program, Division of Cardiology The Ohio State University Medical Center Columbus OH USA.
- Division of Hematology James Cancer Hospital and Solove Research Institute at The Ohio State University Columbus OH USA.
- Center for Biostatistics The Ohio State University Columbus OH USA.
- Cardio-Oncology Program, University of Texas Southwestern Medical Center Texas TX USA.
- Department of Medicine University of Cincinnati Cincinnati OH USA.
- Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine The Ohio State University Columbus OH USA.
ORCID-Profile: Zach Braunstein, Adnan Shaaban, Onaopepo Kola-Kehinde, Eric McLaughlin, Sana Sughra, Sanam Ghazi, Miguel Ruiz, Mussammat Ferdousi, Stephen Sansoterra, Sam Penza, Marcos J de Lima, Hannah Choe, John C Byrd, Jonathan E Brammer, Daniel Addison
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Quartermaine, C., Braunstein, Z., Shaaban, A., Habib, A., Kola-Kehinde, O., McLaughlin, E., Sughra, S., Ghazi, S., Ruiz, M., Toomey, A., Ferdousi, M., Ruz, P., Sharma, S., Sansoterra, S., Byun, W. Y., Vasu, S., Jaglowski, S., Penza, S., de Lima, M. J., …, & Addison, D. (2025). Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation. Journal of the American Heart Association, 14(19). https://doi.org/10.1161/jaha.124.039977
Vancouver
Quartermaine C, Braunstein Z, Shaaban A, Habib A, Kola-Kehinde O, McLaughlin E, et al. Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation. Journal of the American Heart Association. 2025;14(19). doi:10.1161/jaha.124.039977
BibTeX
@article{Quartermaine2025,
author = {Quartermaine, Cooper and Braunstein, Zach and Shaaban, Adnan and Habib, Alma and Kola-Kehinde, Onaopepo and McLaughlin, Eric and Sughra, Sana and Ghazi, Sanam and Ruiz, Miguel and Toomey, Amelia and Ferdousi, Mussammat and Ruz, Patrick and Sharma, Sneha and Sansoterra, Stephen and Byun, Woo Yul and Vasu, Sumithira and Jaglowski, Samantha and Penza, Sam and de Lima, Marcos J and Choe, Hannah and Boateng, Isaiah and Byrd, John C and Brammer, Jonathan E and Addison, Daniel},
title = {Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {19},
doi = {10.1161/jaha.124.039977}
}
EUVIMED